Skip to main content

Table 1 Baseline characteristics of HD patients

From: Erythropoiesis-stimulating agent resistance and mortality in hemodialysis and peritoneal dialysis patients

HD patients

ESA ≤8,000 (units/week)

ESA >8,000 (units/week)

 

Hb ≥11 (g/dl)

Hb <11 (g/dl)

Hb ≥11 (g/dl)

Hb <11 (g/dl)

Number

380

264

158

211

Age (years)

64.5 (13.2)

64.1 (14.4)

64.9 (13.7)

64.2 (12.8)

Sex (%) men

60.4

56.1

65.0

56.4

Weight (kg)

70.6 (12.4)

72.0 (14.3)

74.1 (14.9)

73.6 (14.8)

ESA dose (units/week)

6,000 (4,000-8,000)

6,000 (4,000-8,000)

12,000 (10,000-16,000)

12,000 (12,000-18,000)

ERI (units/week/kg/Hb)

6.5 (2.9)

7.9 (3.4)

16.0 (6.3)

22.3 (13.5)

Primary kidney disease (%)

    

- Diabetes mellitus

10.6

17.4

16.5

15.6

- Glomerulonephritis

11.1

7.6

8.2

8.5

- Renal vascular disease

22.2

21.6

12.7

19.0

- Other

56.2

53.4

62.7

56.9

Comorbidity (%)

    

- Diabetes mellitus

17.1

20.8

27.2

24.2

- Malignancy

7.4

9.8

11.4

18.5

- Cardiovascular disease

39.2

41.3

32.9

40.8

Weekly Kt/V urea (Watson)

3.7 (0.9)

3.5 (0.9)

3.7 (0.8)

3.7 (1.0)

rGFR (ml/min/1.73 m2)

2.9 (1.5-4.4)

2.3 (0.8-3.8)

2.1 (0.8-4.2)

1.5 (0.4-3.2)

Nutritional status (SGA) (%)

    

- Severely malnourished

0.3

2.2

0.8

5.4

- Mild-moderate

19.1

25.4

27.1

37.3

- Well-nourished

80.6

72.4

72.0

57.2

Laboratory values

    

- Hemoglobin (g/dl)

12.1 (11.6-12.7)

10.3 (9.5-10.6)

12.1 (11.6-12.8)

9.8 (9.2-10.5)

- Albumin (g/l)

37.5 (4.5)

36.0 (4.9)

35.6 (4.5)

34.1 (6.0)

- Ferritin (μg/l)

190 (104–380)

175 (94–379)

229 (121–434)

257 (118–511)

- PTH (pmol/l)

12.1 (5.5-23.8)

10.6 (4.7-23.9)

16.3 (6.4-33.7)

10.0 (3.2-23.4)

- CRP (mg/l)

6.0 (3.0-12.0)

6.0 (3.0-15.0)

9.0 (3.0-17.0)

14.0 (6.0-34.5)

  1. Values are presented as mean (SD), median (IQR) or percentage.